New hope for stomach cancer: drug cocktails tested in phase 2 trial

NCT ID NCT05702229

Recruiting now Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times

Summary

This study tests new combinations of drugs for people with advanced stomach cancer that cannot be removed by surgery or has spread. About 163 adults will receive these treatments to see if they can shrink tumors or slow the cancer's growth. The goal is to find better ways to control the disease and improve survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
RECRUITING

Los Angeles, California, 90017, United States
Research Site
WITHDRAWN

Los Angeles, California, 90095, United States
Research Site
RECRUITING

Baton Rouge, Louisiana, 70817, United States
Research Site
RECRUITING

Grand Rapids, Michigan, 49503, United States
Research Site
WITHDRAWN

New Hyde Park, New York, 11042, United States
Research Site
WITHDRAWN

New York, New York, 10028, United States
Research Site
RECRUITING

New York, New York, 10065, United States
Research Site
WITHDRAWN

New York, New York, 11210, United States
Research Site
WITHDRAWN

Shirley, New York, 11967, United States
Research Site
WITHDRAWN

The Bronx, New York, 10469, United States
Research Site
WITHDRAWN

Pittsburgh, Pennsylvania, 15212, United States
Research Site
RECRUITING

Beijing, 100142, China
Research Site
RECRUITING

Hangzhou, 310003, China
Research Site
RECRUITING

Hangzhou, 310020, China
Research Site
RECRUITING

Harbin, 150081, China
Research Site
RECRUITING

Hefei, 230031, China
Research Site
COMPLETED

Kunming, 650118, China
Research Site
RECRUITING

Wuhan, 430079, China
Research Site
RECRUITING

Yinchuan, 750004, China
Research Site
RECRUITING

Zhengzhou, 450052, China
Research Site
RECRUITING

Chūōku, 104-0045, Japan
Research Site
RECRUITING

Kashiwa, 227-8577, Japan
Research Site
RECRUITING

Sunto-gun, 411-8777, Japan
Research Site
RECRUITING

Seoul, 03080, South Korea
Research Site
RECRUITING

Seoul, 03722, South Korea
Research Site
RECRUITING

Seoul, 05505, South Korea
Research Site
RECRUITING

Seoul, 06351, South Korea
Research Site
RECRUITING

Barcelona, 08035, Spain
Research Site
RECRUITING

Elche(Alicante), 03202, Spain
Research Site
RECRUITING

L'Hospitalet de Llobregat, 08908, Spain
Research Site
RECRUITING

Madrid, 28007, Spain
Research Site
RECRUITING

Madrid, 28040, Spain
Research Site
RECRUITING

Santander, 39008, Spain
Research Site
RECRUITING

Hsinchu, 300, Taiwan
Research Site
RECRUITING

Kaohsiung City, 80756, Taiwan
Research Site
RECRUITING

Taichung, 404, Taiwan
Research Site
RECRUITING

Tainan, 70403, Taiwan
Research Site
RECRUITING

Taipei, 10002, Taiwan
Research Site
RECRUITING

Taipei, 11259, Taiwan
Research Site
RECRUITING

Taoyuan, 333, Taiwan
Research Site
WITHDRAWN

Edinburgh, EH4 2XU, United Kingdom
Research Site
RECRUITING

Leeds, LS9 7TF, United Kingdom
Research Site
RECRUITING

London, EC1M 6BQ, United Kingdom
Research Site
RECRUITING

Oxford, OX3 7LE, United Kingdom

Conditions

Explore the condition pages connected to this study.

GASTRIC CANCER